Endo International plc operates as a specialty pharmaceutical firm, developing and marketing both proprietary brand-name and unbranded generic medications across the United States and global markets. Its Branded Pharmaceuticals division offers a diverse array of prescription products, notably including XIAFLEX for the treatment of Dupuytren's contracture in adults, SUPPRELIN LA to address central precocious puberty in children, NASCOBAL nasal spray for managing vitamin B12 deficiency, and AVEED for hypogonadism. Other significant branded offerings encompass QWO, an injectable solution for moderate to severe cellulite in adult women's buttocks; PERCOCET for moderate to moderately-severe pain; TESTOPEL, an implantable pellet indicated for testosterone replacement therapy (TRT); EDEX for erectile dysfunction; and LIDODERM, a topical patch designed to alleviate pain.
